R. Kroon

Effects of liver blood flow on the pharmacokinetics of tissue‐type plasminogen activator (alteplase) during thrombolysis in patients with acute myocardial infarction

L. Huisman, A. Cohen, R. Koster, 1998, Clinical pharmacology and therapeutics.

How to define reference intervals to rule in healthy individuals for clinical trials?

J. V. van Gerven, C. Cobbaert, W. D. den Elzen, 2017, Clinical chemistry and laboratory medicine.

Effects of increased liver blood flow on the kinetics and dynamics of recombinant tissue‐type plasminogen activator

G. Dooijewaard, L. Huisman, A. Cohen, 1996, Clinical pharmacology and therapeutics.

Effects of changing liver blood flow by exercise and food on kinetics and dynamics of saruplase

L. Huisman, A. Cohen, R. Schoemaker, 1995, Clinical pharmacology and therapeutics.

A comparison of the sensitivities of adaptive tracking, eye movement analysis, and visual analog lines to the effects of incremental doses of temazepam in healthy volunteers

H. Schoemaker, M. Pieters, D. Breimer, 1991, Clinical pharmacology and therapeutics.

Effect of Changes in Liver Blood Flow on the Pharmacokinetics of Saruplase in Patients with Acute Myocardial Infarction

R. Schoemaker, A. Cohen, W. Günzler, 1997, Thrombosis and Haemostasis.

Effects of temazepam on saccadic eye movements: Concentration‐effect relationships in individual volunteers

H. Schoemaker, M. Pieters, D. Breimer, 1992, Clinical pharmacology and therapeutics.

Tolrestat pharmacokinetic and pharmacodynamic effects on red blood cell sorbitol levels in normal volunteers and in patients with insulin‐dependent diabetes

W. Jusko, A. Cohen, S. Chiang, 1995, Clinical pharmacology and therapeutics.

Influence of gastric acidity on the bioavailability of digoxin.

A. Cohen, R. Schoemaker, A. V. van Vliet, 1991, Annals of internal medicine.